424 related articles for article (PubMed ID: 11564647)
1. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
Szabo B; Fritz T; Wedzony K
Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
Szabo B; Bock C; Nordheim U; Niederhoffer N
Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
[TBL] [Abstract][Full Text] [Related]
4. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
Chan CK; Head GA
J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of sympathoinhibition by imidazolines.
Szabo B; Urban R
Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
Godwin SJ; Tortelli CF; Parkin ML; Head GA
J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
[TBL] [Abstract][Full Text] [Related]
8. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
9. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
[TBL] [Abstract][Full Text] [Related]
10. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304.
Urban R; Szabo B; Starke K
Eur J Pharmacol; 1995 Aug; 282(1-3):29-37. PubMed ID: 7498287
[TBL] [Abstract][Full Text] [Related]
11. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
12. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
Chan CK; Burke SL; Head GA
J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
[TBL] [Abstract][Full Text] [Related]
13. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of clonidine-like drugs in pithed rabbits.
Pompermayer K; Salgado MC; Feldman J; Bousquet P
Hypertension; 1999 Oct; 34(4 Pt 2):1012-5. PubMed ID: 10523400
[TBL] [Abstract][Full Text] [Related]
15. No evidence for functional imidazoline receptors on locus coeruleus neurons.
Szabo B; Fröhlich R; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
[TBL] [Abstract][Full Text] [Related]
17. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
Parkin ML; Godwin SJ; Head GA
J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
[TBL] [Abstract][Full Text] [Related]
19. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
Head GA; Burke SL; Chan CK
J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
[TBL] [Abstract][Full Text] [Related]
20. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
